|
1
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Aljiffry M, Abdulelah A, Walsh M,
Peltekian K, Alwayn I and Molinari M: Evidence-based approach to
cholangiocarcinoma: A systematic review of the current literature.
J Am Coll Surg. 208:134–147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sia D, Tovar V, Moeini A and Llovet JM:
Intrahepatic cholangiocarcinoma: Pathogenesis and rationale for
molecular therapies. Oncogene. 32:4861–4870. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou
Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, et
al: Intrahepatic cholangiocarcinoma: Rising frequency, improved
survival, and determinants of outcome after resection. Ann Surg.
248:84–96. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dodson RM, Weiss MJ, Cosgrove D, Herman
JM, Kamel I, Anders R, Geschwind JF and Pawlik TM: Intrahepatic
cholangiocarcinoma: Management options and emerging therapies. J Am
Coll Surg. 217:736–750.e4. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sirica AE, Dumur CI, Campbell DJ, Almenara
JA, Ogunwobi OO and Dewitt JL: Intrahepatic cholangiocarcinoma
progression: Prognostic factors and basic mechanisms. Clin
Gastroenterol Hepatol. 7 11 Suppl:S68–S78. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Isin M and Dalay N: lncRNAs and neoplasia.
Clin Chim Acta. 444:280–288. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sahu A, Singhal U and Chinnaiyan AM: Long
noncoding RNAs in cancer: From function to translation. Trends
Cancer. 1:93–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ghoussaini M, Song H, Koessler T, Al Olama
AA, Kote-Jarai Z, Driver KE, Pooley KA, Ramus SJ, Kjaer SK, Hogdall
E, et al: Multiple loci with different cancer specificities within
the 8q24 gene desert. J Natl Cancer Inst. 100:962–966. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertucci F, Lagarde A, Ferrari A, Finetti
P, Charafe-Jauffret E, Van Laere S, Adelaide J, Viens P, Thomas G,
Birnbaum D and Olschwang S: 8q24 cancer risk allele associated with
major metastatic risk in inflammatory breast cancer. PLoS One.
7:e379432012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barr Fritcher EG, Voss JS, Brankley SM,
Campion MB, Jenkins SM, Keeney ME, Henry MR, Kerr SM, Chaiteerakij
R, Pestova EV, et al: An optimized set of fluorescence in situ
hybridization probes for detection of pancreatobiliary tract cancer
in cytology brush samples. Gastroenterology. 149:1813–1824.e1.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fan YH, Fang H, Ji CX, Xie H, Xiao B and
Zhu XG: Long noncoding RNA CCAT2 can predict metastasis and poor
prognosis: A meta-analysis. Clin Chim Acta. 466:120–126. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qiu M, Xu Y, Yang X, Wang J, Hu J, Xu L
and Yin R: CCAT2 is a lung adenocarcinoma-specific long non-coding
RNA and promotes invasion of non-small cell lung cancer. Tumour
Biol. 35:5375–5380. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang S, Qing C, Huang Z and Zhu Y: The
long non-coding RNA CCAT2 is up-regulated in ovarian cancer and
associated with poor prognosis. Diagn Pathol. 11:492016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou N, Si Z, Li T, Chen G, Zhang Z and Qi
H: Long non-coding RNA CCAT2 functions as an oncogene in
hepatocellular carcinoma, regulating cellular proliferation,
migration and apoptosis. Oncol Lett. 12:132–138. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Qiu M, Xu Y, Li M, Dong G, Mao Q,
Yin R and Xu L: Long noncoding RNA CCAT2 correlates with smoking in
esophageal squamous cell carcinoma. Tumour Biol. 36:5523–5528.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zeng J, Du T, Song Y, Gao Y, Li F, Wu R,
Chen Y, Li W, Zhou H, Yang Y and Pei Z: Knockdown of long noncoding
RNA CCAT2 inhibits cellular proliferation, invasion, and
epithelial-mesenchymal transition in glioma cells. Oncol Res.
25:913–921. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kasagi Y, Oki E, Ando K, Ito S, Iguchi T,
Sugiyama M, Nakashima Y, Ohgaki K, Saeki H, Mimori K and Maehara Y:
The expression of CCAT2, a novel long noncoding RNA transcript, and
rs6983267 single-nucleotide polymorphism genotypes in colorectal
cancers. Oncology. 92:48–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cai Y, He J and Zhang D: Long noncoding
RNA CCAT2 promotes breast tumor growth by regulating the Wnt
signaling pathway. Onco Targets Ther. 8:2657–2664. 2015.PubMed/NCBI
|
|
25
|
Hua F, Li CH, Chen XG and Liu XP: Long
noncoding RNA CCAT2 knockdown suppresses tumorous progression by
sponging miR-424 in epithelial ovarian vancer. Oncol Res. May
21–2017.(Epub ahead of print).
|
